Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES.
Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
Pentosyltransferases that catalyze the reaction between a pyrimidine nucleoside and orthophosphate to form a free pyrimidine and ribose-5-phosphate.
Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES.
Pyrimidines with a RIBOSE and phosphate attached that can polymerize to form DNA and RNA.
An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate.
A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
Proteins involved in the transport of NUCLEOSIDES across cellular membranes.
Uridine is a nucleoside, specifically a derivative of pyrimidine, that is composed of a uracil molecule joined to a ribose sugar molecule through a β-N1 glycosidic bond, and has significant roles in RNA synthesis, energy transfer, and cell signaling.
Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE.
2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies.
An enzyme that catalyzes the phosphorylation of uridine and cytidine to uridine 5'-phosphate and cytidine 5'-phosphate, respectively. ATP, dUTP, dGTP, and dATP are effective phosphate donors. EC 2.7.1.48.
Dimers found in DNA chains damaged by ULTRAVIOLET RAYS. They consist of two adjacent PYRIMIDINE NUCLEOTIDES, usually THYMINE nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers block DNA REPLICATION.
Sulfhydryl analog of INOSINE that inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. It has been used similarly to MERCAPTOPURINE in the treatment of leukemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p503)
A subtype of equilibrative nucleoside transporter proteins that is sensitive to inhibition by 4-nitrobenzylthioinosine.
Coronary vasodilator with some antiarrhythmic activity.
A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)
An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
A purine or pyrimidine base bonded to DEOXYRIBOSE.
Thymidine is a pyrimidine nucleoside, consisting of a thymine base linked to a deoxyribose sugar by a β-N1-glycosidic bond, which plays a crucial role in DNA replication and repair processes as one of the four nucleosides in DNA.
Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine.
An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21.
A subtype of equilibrative nucleoside transporter proteins that is insensitive to inhibition by 4-nitrobenzylthioinosine.
A genus of small tapeworms of birds and mammals.
An antiviral derivative of THYMIDINE used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HERPES SIMPLEX virus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p557)
Uracil is a nitrogenous base, specifically a pyrimidine derivative, which constitutes one of the four nucleobases in the nucleic acid of RNA (ribonucleic acid), pairing with adenine via hydrogen bonds during base-pairing. (25 words)
Uracil nucleotides are chemical compounds that consist of a uracil base, a sugar molecule called ribose, and one or more phosphate groups, which play crucial roles in DNA replication, repair, and gene expression as well as in RNA synthesis.
A class of organic compounds containing two ring structures, one of which is made up of more than one kind of atom, usually carbon plus another atom. The heterocycle may be either aromatic or nonaromatic.
A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids.
An enzyme that catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., UMP, to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4.
The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
The rate dynamics in chemical or physical systems.
A class of sodium-independent nucleoside transporters that mediate the facilitative transport of NUCLEOSIDES.
Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7.
A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1.
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS.
A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds.
Deoxycytidine is a nucleoside consisting of the pentose sugar deoxyribose linked to the nitrogenous base cytosine, which plays a crucial role in DNA replication and repair processes within cells.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
An enzyme that is found in mitochondria and in the soluble cytoplasm of cells. It catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside diphosphate, e.g., UDP, to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.6.
An enzyme which catalyzes an endonucleolytic cleavage near PYRIMIDINE DIMERS to produce a 5'-phosphate product. The enzyme acts on the damaged DNA strand, from the 5' side of the damaged site.
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
Orotic acid, also known as pyrophosphoric acid dihydrate, is a organic compound that plays a role in the biosynthesis of pyrimidines, and elevated levels of orotic acid in urine can indicate certain genetic disorders or liver dysfunction.
The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
Purines attached to a RIBOSE and a phosphate that can polymerize to form DNA and RNA.
That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants.
The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions.
Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING).
The enzyme catalyzing the formation of orotidine-5'-phosphoric acid (orotidylic acid) from orotic acid and 5-phosphoribosyl-1-pyrophosphate in the course of pyrimidine nucleotide biosynthesis. EC 2.4.2.10.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Transport proteins that carry specific substances in the blood or across cell membranes.
Pyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties.
A modified nucleoside which is present in the first position of the anticodon of tRNA-tyrosine, tRNA-histidine, tRNA-asparagine and tRNA-aspartic acid of many organisms. It is believed to play a role in the regulatory function of tRNA. Nucleoside Q can be further modified to nucleoside Q*, which has a mannose or galactose moiety linked to position 4 of its cyclopentenediol moiety.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A purine base and a fundamental unit of ADENINE NUCLEOTIDES.
An enzyme which catalyzes the hydrolysis of nucleoside triphosphates to nucleoside diphosphates. It may also catalyze the hydrolysis of nucleotide triphosphates, diphosphates, thiamine diphosphates and FAD. The nucleoside triphosphate phosphohydrolases I and II are subtypes of the enzyme which are found mostly in viruses.
An enzyme that, in the course of pyrimidine biosynthesis, catalyzes ring closure by removal of water from N-carbamoylaspartate to yield dihydro-orotic acid. EC 3.5.2.3.
An enzyme that catalyzes the reactivation by light of UV-irradiated DNA. It breaks two carbon-carbon bonds in PYRIMIDINE DIMERS in DNA.
Established cell cultures that have the potential to propagate indefinitely.
The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH = log 1/2[1/(H+)], where (H+) is the hydrogen ion concentration in gram equivalents per liter of solution. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
An enzyme that catalyzes the conversion of carbamoyl phosphate and L-aspartate to yield orthophosphate and N-carbamoyl-L-aspartate. (From Enzyme Nomenclature, 1992) EC 2.1.3.2.
Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.

Base pairing of anhydrohexitol nucleosides with 2,6-diaminopurine, 5-methylcytosine and uracil asbase moiety. (1/258)

Hexitol nucleic acids (HNAs) with modified bases (5-methylcytosine, 2,6-diaminopurine or uracil) were synthesized. The introduction of the 5-methylcytosine base demonstrates that N -benzoylated 5-methylcytosyl-hexitol occurs as the imino tautomer. The base pairing systems (G:CMe, U:D, T:D and U:A) obey Watson-Crick rules. Substituting hT for hU, hCMefor hC and hD for hA generally leads to increased duplex stability. In a single case, replacement of hC by hCMedid not result in duplex stabilization. This sequence-specific effect could be explained by the geometry of the model duplex used for carrying out the thermal stability study. Generally, polypurine HNA sequences give more stable duplexes with their RNA complement than polypyrimidine HNA sequences. This observation supports the hypothesis that, besides changes in stacking pattern, the difference in conformational stress between purine and pyrimidine nucleosides may contribute to duplex stability. Introduction of hCMeand hD in HNA sequences further increases the potential of HNA to function as a steric blocking agent.  (+info)

Assay for reactive oxygen species-induced DNA damage: measurement of the formamido and thymine glycol lesions. (2/258)

A 32P-postlabeling assay has been developed for the simultaneous detection of the thymine glycol lesion and the formamido remnant of pyrimidine bases in DNA exposed to reactive oxygen species (ROS). The formamido lesion is a principal lesion produced in X-irradiated DNA oligomers when oxygen is available to mediate the damage process. Production of the well-known thymine glycol lesion is less dependent on the concentration of oxygen. These two lesions have the common property that they make the phosphoester bond 3' to the modified nucleoside resistant to hydrolysis by nuclease P1. Our assay uses 32P-postlabeling to measure these lesions in the form of modified dimers obtained from DNA by nuclease P1 digestion. Appropriate carriers and internal standards have been chemically synthesized to improve the reliability and accuracy of the assay. The measurements were accomplished on 1-microgram samples of DNA.  (+info)

Bystander effect of purine nucleoside analogues in HSV-1 tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues. (3/258)

Introduction of the herpes simplex virus type 1 thymidine kinase gene into tumor cells, followed by the administration of the antiherpes nucleoside analogue ganciclovir has been demonstrated to be effective in eliminating solid tumors in animals. The success of this combination treatment largely depends on the bystander effect, i.e. the killing of nontransfected tumor cells by activated drug carried over from the nearby herpes thymidine kinase (tk) gene-transfected cells. We evaluated the in vitro bystander effect of several antiherpes purine and pyrimidine nucleoside analogues, using a colorimetric assay. All pyrimidine nucleoside analogues, including (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU), showed low, if any, bystander killing effect. In contrast, purine nucleoside analogues, such as ganciclovir, were endowed with a pronounced bystander killer effect. Lobucavir (Cyclobut-G), a ganciclovir analogue, displayed a two- to three-fold more pronounced bystander killer effect than ganciclovir, eliminating, at a concentration of 10 microM, 75% and 90% of a cell population that contained 5% and 10% tk gene-transfected cells, respectively. These findings were corroborated by autoradiographic analysis that showed that 2'-3H-BVDU metabolites formed in the herpes tk gene-transfected tumor cells were much less efficiently incorporated in the DNA of bystander cells than 8-3H-GCV. This indicates that, under the same experimental conditions, BVDU metabolites are less prone to pass the gap junctions than GCV metabolites.  (+info)

Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2. (4/258)

hCNT1 and hCNT2 mediate concentrative (Na(+)-linked) cellular uptake of nucleosides and nucleoside drugs by human cells and tissues. The two proteins (650 and 658 residues, 71 kDa) are 72% identical in sequence and contain 13 putative transmembrane helices (TMs). When produced in Xenopus oocytes, recombinant hCNT1 is selective for pyrimidine nucleosides (system cit), whereas hCNT2 is selective for purine nucleosides (system cif). Both transport uridine. We have used (i) chimeric constructs between hCNT1 and hCNT2, (ii) sequence comparisons with a newly identified broad specificity concentrative nucleoside transporter (system cib) from Eptatretus stouti, the Pacific hagfish (hfCNT), and (iii) site-directed mutagenesis of hCNT1 to identify two sets of adjacent residues in TMs 7 and 8 of hCNT1 (Ser(319)/Gln(320) and Ser(353)/Leu(354)) that, when converted to the corresponding residues in hCNT2 (Gly(313)/Met(314) and Thr(347)/Val(348)), changed the specificity of the transporter from cit to cif. Mutation of Ser(319) in TM 7 of hCNT1 to Gly enabled transport of purine nucleosides, whereas concurrent mutation of Gln(320) to Met (which had no effect on its own) augmented this transport. The additional mutation of Ser(353) to Thr in TM 8 converted hCNT1/S319G/Q320M, from cib to cif, but with relatively low adenosine transport activity. Additional mutation of Leu(354) to Val (which had no effect on its own) increased the adenosine transport capability of hCNT1/S319G/Q320M/S353T, producing a full cif-type transporter phenotype. On its own, the S353T mutation converted hCNT1 into a transporter with novel uridine-selective transport properties. Helix modeling of hCNT1 placed Ser(319) (TM 7) and Ser(353) (TM 8) within the putative substrate translocation channel, whereas Gln(320) (TM 7) and Leu(354) (TM 8) may exert their effects through altered helix packing.  (+info)

Hydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogs. (5/258)

Hydroxyurea has been shown to potentiate the anti-human immunodeficiency virus activities of 2',3'-dideoxynucleoside analogs such as didanosine. We have now evaluated in vitro the effect of hydroxyurea on the antiherpesvirus activities of several nucleoside analogs (acyclovir [ACV], ganciclovir [GCV], penciclovir [PCV], lobucavir [LBV], (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine [H2G], and brivudin and nucleoside phosphonate analogs (cidofovir [CDV] and adefovir [ADV]). When evaluated in cytopathic effect (CPE) reduction assays, hydroxyurea by itself had little effect on CPE progression and potentiated in a subsynergistic (herpes simplex virus type 1 [HSV-1]) to synergistic (HSV-2) fashion the antiviral activities of ACV, GCV, PCV, LBV, H2G, ADV, and CDV. Hydroxyurea also caused marked increases in the activities of ACV, GCV, PCV, LBV, and H2G (compounds that depend for their activation on a virus-encoded thymidine kinase [TK]) against TK-deficient (TK(-)) HSV-1. In fact, in combination with hydroxyurea the 50% effective concentrations of these compounds for inhibition of TK(-) HSV-1-induced CPE decreased from values of 20 to > or = 100 microg/ml (in the absence of hydroxyurea) to values of 1 to 5 microg/ml (in the presence of hydroxyurea at 25 to 100 microg/ml). When evaluated in a single-cycle virus yield reduction assay, hydroxyurea at a concentration of 100 microg/ml inhibited progeny virus production by 60 to 90% but had little effect on virus yield at a concentration of 25 microg/ml. Under these assay conditions hydroxyurea still elicited a marked potentiating effect on the antiherpesvirus activities of GCV and CDV, but this effect was less pronounced than that in the CPE reduction assay. It is conceivable that the potentiating effect of hydroxyurea stems from a depletion of the intracellular deoxynucleoside triphosphate pools, thus favoring the triphosphates of the nucleoside analogues (or the diphosphates of the nucleoside phosphonate analogues) in their competition with the natural nucleotides at the viral DNA polymerase level. The possible clinical implications of these findings are discussed.  (+info)

Elaboration of pyrimidine-specific nucleosidases by human lymphoblastoid cells of established cultures. (6/258)

Pyrimidine-specific nucleosidases were released rapidly by human lymphoblastoid cells of established cultures when incubated under certain culture conditions having no adverse affect on their viability or morphology. Nucleosidase production was not restricted to any particular type of lymphoblastoid line; enzymes with a high level of activity were elaborated by cells of cultures initiated from healthy subjects and patients with uncontrolled lymphocytic or myelocytic leukemia, as well as by cells of cultures exhibiting mostly B- or T-cell properties. Tritiated thymine and uracil, which were not incorporated to any appreciable extent by DNA- and RNA-synthesizing cells, were identified by paper chromatography as the primary products arising from nucleosidase degradation of radiolabeled thymidine, uridine, and cytidine. Neither adenosine nor guanosine was catabolized. These heat-labile and ultraviolet-sensitive enzymes with a molecular weight of 5 to 10 X 10(4) did not affect the viability, morphology, or proliferation of lymphocytes in mitogenactivated cultures, lymphoblastoid cells in long-term cultures, or fibroblasts in monolayer cultures.  (+info)

Rapid screening of high-risk patients for disorders of purine and pyrimidine metabolism using HPLC-electrospray tandem mass spectrometry of liquid urine or urine-soaked filter paper strips. (7/258)

BACKGROUND: A rapid and specific screening method for patients at risk of inherited disorders of purine and pyrimidine metabolism is desirable because symptoms are varied and nonspecific. The aim of this study was to develop a rapid and specific method for screening with use of liquid urine samples or urine-soaked filter paper strips. METHODS: Reverse-phase HPLC was combined with electrospray ionization (ESI), tandem mass spectrometry (MS/MS), and detection performed by multiple reaction monitoring. Transitions and instrument settings were established for 17 purines or pyrimidines. Stable-isotope-labeled reference compounds were used as internal standards when available. RESULTS: Total analysis time of this method was 15 min, approximately one-third that of conventional HPLC with ultraviolet detection. Recoveries were 96-107% in urine with added analyte, with two exceptions (hypoxanthine, 64%; xanthine, 79%), and 89-110% in urine-soaked filter paper strips, with three exceptions (hypoxanthine, 65%; xanthine, 77%; 5-hydroxymethyluracil, 80%). The expected abnormalities were easily found in samples from patients with purine nucleoside phosphorylase deficiency, ornithine transcarbamylase deficiency, molybdenum cofactor deficiency, adenylosuccinase deficiency, or dihydropyrimidine dehydrogenase deficiency. CONCLUSIONS: HPLC-ESI MS/MS of urine allows rapid screening for disorders of purine and pyrimidine metabolism. The filter paper strips offer the advantage of easy collection, transport, and storage of the urine samples.  (+info)

Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine radiosensitization in U251 human glioblastoma xenografts. (8/258)

In anticipation of an initial clinical Phase I trial in patients with high-grade gliomas of p.o. administered 5-iodo2-pyrimidinone-2'-deoxyribose (IPdR) given daily for 14 days as a prodrug for 5-iodo-2'-deoxyuridine (IUdR)-mediated tumor radiosensitization, we determined the systemic toxicities and the percentage IUdR-DNA incorporation in normal athymic mouse tissues and a human glioblastoma xenograft (U251) after this dosing schedule of IPdR. Using a tumor regrowth assay of s.c. U251 xenografts, we also compared radiosensitization with this IPdR-dosing schedule to radiation therapy (XRT) alone (2 Gy/day for 4 days) or to XRT after continuous infusion IUdR for 14 days at the maximum tolerated dose in mice (100 mg/kg/day). Athymic mice with and without U251 s.c. xenografts tolerated 750 or 1500 mg/kg/day of p.o. IPdR (using gastric lavage) for 14 days without weight loss or activity level changes during treatment and for a 28-day posttreatment observation period. The percentage IUdR-DNA incorporation in U251 tumor cells was significantly higher after p.o. IPdR (750 and 1500 mg/kg/day) for 14 days (3.1 +/- 0.2% and 3.7 +/- 0.3%, respectively) than continuous infusion IUdR for 14 days (1.4 +/- 0.1%). Compared to XRT alone, a significant sensitizer enhancement ratio (SER) was found with the combination of p.o. IPdR (1500 mg/kg/d) + XRT (SER = 1.31; P = 0.05) but not for the combination of continuous infusion IUdR + XRT (SER = 1.07; P = 0.57) in the U251 xenografts. The percentage IUdR-DNA incorporation after IPdR at 1500 mg/kg/day for 14 days in normal bone marrow, normal small intestine, and normal liver were 1.2 +/-0.2%, 3.3 +/- 0.3%, and 0.2 +/- 0.1%, respectively. We conclude that a 14-day p.o. schedule of IPdR at up to 1500 mg/kg/day results in no significant systemic toxicity in athymic mice and is associated with significant radiosensitization using this human glioblastoma multiforme xenograft model. Based on these data and our previously published data using shorter IPdR dosing schedules, which also demonstrate an improved therapeutic index for IPdR compared to IUdR, an initial clinical Phase I and pharmacokinetic study of p.o. IPdR daily for 14 days is being designed.  (+info)

Pyrimidine nucleosides are organic compounds that consist of a pyrimidine base (a heterocyclic aromatic ring containing two nitrogen atoms and four carbon atoms) linked to a sugar molecule, specifically ribose or deoxyribose, via a β-glycosidic bond. The pyrimidine bases found in nucleosides can be cytosine (C), thymine (T), or uracil (U). When the sugar component is ribose, it is called a pyrimidine nucleoside, and when it is linked to deoxyribose, it is referred to as a deoxy-pyrimidine nucleoside. These molecules play crucial roles in various biological processes, particularly in the structure and function of nucleic acids such as DNA and RNA.

A nucleoside is a biochemical molecule that consists of a pentose sugar (a type of simple sugar with five carbon atoms) covalently linked to a nitrogenous base. The nitrogenous base can be one of several types, including adenine, guanine, cytosine, thymine, or uracil. Nucleosides are important components of nucleic acids, such as DNA and RNA, which are the genetic materials found in cells. They play a crucial role in various biological processes, including cell division, protein synthesis, and gene expression.

Pyrimidine phosphorylases are a group of enzymes that play a crucial role in the metabolism of pyrimidines, which are nitrogenous bases found in nucleic acids such as DNA and RNA. These enzymes catalyze the reversible phosphorolytic cleavage of pyrimidine nucleosides into ribose-1-phosphate and a free base.

There are two main types of pyrimidine phosphorylases: cytosine phosphorylase (CP) and thymidine phosphorylase (TP). CP catalyzes the conversion of cytosine to uracil, while TP converts thymidine to thymine. These enzymes are important in maintaining the balance of pyrimidines in cells and are also involved in the salvage pathway for nucleotide synthesis.

Deficiencies or mutations in these enzymes can lead to various genetic disorders, including neurological and developmental abnormalities. Additionally, TP has been studied as a potential target for cancer therapy due to its role in angiogenesis and tumor growth.

Purine nucleosides are fundamental components of nucleic acids, which are the genetic materials found in all living organisms. A purine nucleoside is composed of a purine base (either adenine or guanine) linked to a sugar molecule, specifically ribose in the case of purine nucleosides.

The purine base and sugar moiety are joined together through a glycosidic bond at the 1' position of the sugar. These nucleosides play crucial roles in various biological processes, including energy transfer, signal transduction, and as precursors for the biosynthesis of DNA and RNA.

In the human body, purine nucleosides can be derived from the breakdown of endogenous nucleic acids or through the dietary intake of nucleoproteins. They are further metabolized to form uric acid, which is eventually excreted in the urine. Elevated levels of uric acid in the body can lead to the formation of uric acid crystals and contribute to the development of gout or kidney stones.

Pyrimidine nucleotides are organic compounds that play crucial roles in various biological processes, particularly in the field of genetics and molecular biology. They are the building blocks of nucleic acids, which include DNA and RNA, and are essential for the storage, transmission, and expression of genetic information within cells.

Pyrimidine is a heterocyclic aromatic organic compound similar to benzene and pyridine, containing two nitrogen atoms at positions 1 and 3 of the six-member ring. Pyrimidine nucleotides are derivatives of pyrimidine, which contain a phosphate group, a pentose sugar (ribose or deoxyribose), and one of three pyrimidine bases: cytosine (C), thymine (T), or uracil (U).

* Cytosine is present in both DNA and RNA. It pairs with guanine via hydrogen bonding during DNA replication and transcription.
* Thymine is exclusively found in DNA, where it pairs with adenine through two hydrogen bonds.
* Uracil is a pyrimidine base that replaces thymine in RNA molecules and pairs with adenine via two hydrogen bonds during RNA transcription.

Pyrimidine nucleotides, along with purine nucleotides (adenine, guanine, and their derivatives), form the fundamental units of nucleic acids, contributing to the structure, function, and regulation of genetic material in living organisms.

Uridine phosphorylase is an enzyme that plays a role in the metabolism of nucleosides, specifically uridine. The medical definition of 'uridine phosphorylase' is:

An enzyme (EC 2.4.2.3) involved in the reversible phosphorolysis of uridine to uracil and ribose-1-phosphate. This enzyme also catalyzes the phosphorolytic cleavage of other pyrimidine nucleosides, such as cytidine and thymidine, into their respective bases and ribose-1-phosphate. Uridine phosphorylase has a role in the salvage pathway of pyrimidine nucleotide biosynthesis and is found in various tissues, including the liver, intestines, and blood cells. Deficiency or dysfunction of uridine phosphorylase can lead to impaired nucleotide metabolism and may be associated with certain medical conditions, such as hereditary orotic aciduria.

Pyrimidines are heterocyclic aromatic organic compounds similar to benzene and pyridine, containing two nitrogen atoms at positions 1 and 3 of the six-member ring. They are one of the two types of nucleobases found in nucleic acids, the other being purines. The pyrimidine bases include cytosine (C) and thymine (T) in DNA, and uracil (U) in RNA, which pair with guanine (G) and adenine (A), respectively, through hydrogen bonding to form the double helix structure of nucleic acids. Pyrimidines are also found in many other biomolecules and have various roles in cellular metabolism and genetic regulation.

Nucleoside transport proteins (NTTs) are membrane-bound proteins responsible for the facilitated diffusion of nucleosides and related deoxynucleosides across the cell membrane. These proteins play a crucial role in the uptake of nucleosides, which serve as precursors for DNA and RNA synthesis, as well as for the salvage of nucleotides in the cell.

There are two main types of NTTs: concentrative (or sodium-dependent) nucleoside transporters (CNTs) and equilibrative (or sodium-independent) nucleoside transporters (ENTs). CNTs mainly facilitate the uptake of nucleosides against a concentration gradient, using the energy derived from the sodium ion gradient. In contrast, ENTs mediate bidirectional transport, allowing for the equalization of intracellular and extracellular nucleoside concentrations.

Nucleoside transport proteins have been identified in various organisms, including humans, and are involved in numerous physiological processes, such as cell proliferation, differentiation, and survival. Dysregulation of NTTs has been implicated in several pathological conditions, including cancer and viral infections, making them potential targets for therapeutic intervention.

Uridine is a nucleoside that consists of a pyrimidine base (uracil) linked to a pentose sugar (ribose). It is a component of RNA, where it pairs with adenine. Uridine can also be found in various foods such as beer, broccoli, yeast, and meat. In the body, uridine can be synthesized from orotate or from the breakdown of RNA. It has several functions, including acting as a building block for RNA, contributing to energy metabolism, and regulating cell growth and differentiation. Uridine is also available as a dietary supplement and has been studied for its potential benefits in various health conditions.

Pentosyltransferases are a group of enzymes that catalyze the transfer of a pentose (a sugar containing five carbon atoms) molecule from one compound to another. These enzymes play important roles in various biochemical pathways, including the biosynthesis of nucleotides, glycoproteins, and other complex carbohydrates.

One example of a pentosyltransferase is the enzyme that catalyzes the addition of a ribose sugar to form a glycosidic bond with a purine or pyrimidine base during the biosynthesis of nucleotides, which are the building blocks of DNA and RNA.

Another example is the enzyme that adds xylose residues to proteins during the formation of glycoproteins, which are proteins that contain covalently attached carbohydrate chains. These enzymes are essential for many biological processes and have been implicated in various diseases, including cancer and neurodegenerative disorders.

Cytidine is a nucleoside, which consists of the sugar ribose and the nitrogenous base cytosine. It is an important component of RNA (ribonucleic acid), where it pairs with guanosine via hydrogen bonding to form a base pair. Cytidine can also be found in some DNA (deoxyribonucleic acid) sequences, particularly in viral DNA and in mitochondrial DNA.

Cytidine can be phosphorylated to form cytidine monophosphate (CMP), which is a nucleotide that plays a role in various biochemical reactions in the body. CMP can be further phosphorylated to form cytidine diphosphate (CDP) and cytidine triphosphate (CTP), which are involved in the synthesis of lipids, glycogen, and other molecules.

Cytidine is also available as a dietary supplement and has been studied for its potential benefits in treating various health conditions, such as liver disease and cancer. However, more research is needed to confirm these potential benefits and establish safe and effective dosages.

Deoxyuridine is a chemical compound that is a component of DNA. It is a nucleoside, which means it consists of a sugar (deoxyribose) linked to a nitrogenous base (uracil). In the case of deoxyuridine, the uracil is not methylated, which differentiates it from thymidine.

Deoxyuridine can be converted into deoxyuridine monophosphate (dUMP) by the enzyme thymidine kinase. The dUMP can then be converted into deoxythymidine triphosphate (dTTP), which is a building block of DNA, through a series of reactions involving other enzymes.

Deoxyuridine has been used in research and medicine as a marker for DNA synthesis and repair. It can also be used to inhibit the growth of certain types of cells, such as cancer cells, by disrupting their DNA synthesis.

Uridine kinase is an enzyme that phosphorylates the pyrimidine nucleoside uridine to produce uridine monophosphate (UMP). This reaction plays a crucial role in the salvage pathway of pyrimidine nucleotide synthesis, which recycles nucleosides generated from the degradation of RNA.

The human genome encodes two isoforms of uridine kinase, UCK1 and UCK2, which share a high degree of sequence similarity but have distinct tissue expression patterns and subcellular localization. UCK1 is primarily expressed in the liver and kidney, while UCK2 is more widely expressed in various tissues.

Uridine kinase activity has been implicated in several physiological processes, including the regulation of intracellular nucleotide pools, the biosynthesis of glycosaminoglycans and proteoglycans, and the modulation of antiviral responses. Dysregulation of uridine kinase activity has been associated with various pathological conditions, such as cancer, viral infections, and neurological disorders.

Pyrimidine dimers are a type of DNA lesion that form when two adjacent pyrimidine bases on the same strand of DNA become covalently linked, usually as a result of exposure to ultraviolet (UV) light. The most common type of pyrimidine dimer is the cyclobutane pyrimidine dimer (CPD), which forms when two thymine bases are linked together in a cyclobutane ring structure.

Pyrimidine dimers can distort the DNA helix and interfere with normal replication and transcription processes, leading to mutations and potentially cancer. The formation of pyrimidine dimers is a major mechanism by which UV radiation causes skin damage and increases the risk of skin cancer.

The body has several mechanisms for repairing pyrimidine dimers, including nucleotide excision repair (NER) and base excision repair (BER). However, if these repair mechanisms are impaired or overwhelmed, pyrimidine dimers can persist and contribute to the development of cancer.

Thioinosine is not a medical term itself, but it is a chemical compound that has been studied in the field of medical research. Thioinosine is an analogue of the nucleoside inosine, where the oxygen atom in the heterocyclic ring is replaced by a sulfur atom.

In the context of medical research, thioinosine has been investigated for its potential immunomodulatory and antiviral properties. It has been studied as an inhibitor of certain enzymes involved in the replication of viruses, such as HIV and hepatitis C virus. However, it is not currently approved for use as a medication in clinical practice.

Equilibrative Nucleoside Transporter 1 (ENT1), also known as SLC29A1, is a protein that functions as a membrane transport protein. It is responsible for the facilitated diffusion of nucleosides and some related drugs across the cell membrane. The term "equilibrative" refers to the fact that this transporter moves substrates down their concentration gradient, meaning it facilitates the movement of molecules from an area of high concentration to an area of low concentration. ENT1 is widely expressed in various tissues, including the liver, kidney, intestine, and brain, playing a crucial role in nucleoside homeostasis and the cellular uptake of nucleoside-analog drugs used in cancer chemotherapy.

Dilazep is a medication that belongs to a class of drugs called calcium channel blockers. It is primarily used in the management of angina pectoris, which is chest pain caused by reduced blood flow to the heart muscle. Dilazep works by relaxing and widening the blood vessels that supply the heart, thereby improving blood flow and reducing the workload on the heart.

The chemical name for Dilazep is (E)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid diamide. It is not commonly used in many countries, and other calcium channel blockers such as verapamil, nifedipine, and amlodipine are more frequently prescribed for the treatment of angina pectoris.

It's important to note that like all medications, Dilazep can have side effects, including headache, dizziness, and swelling in the extremities. It should be used under the close supervision of a healthcare provider, who can monitor its effectiveness and potential side effects.

Guanosine is a nucleoside that consists of a guanine base linked to a ribose sugar molecule through a beta-N9-glycosidic bond. It plays a crucial role in various biological processes, such as serving as a building block for DNA and RNA during replication and transcription. Guanosine triphosphate (GTP) and guanosine diphosphate (GDP) are important energy carriers and signaling molecules involved in intracellular regulation. Additionally, guanosine has been studied for its potential role as a neuroprotective agent and possible contribution to cell-to-cell communication.

Floxuridine is a chemotherapeutic antimetabolite medication that is primarily used in the treatment of colon cancer. It is a fluorinated pyrimidine nucleoside analogue, which means it is similar in structure to the building blocks of DNA and RNA, and can be incorporated into these molecules during cell division, disrupting their normal function and preventing cell replication.

Floxuridine works by inhibiting the enzyme thymidylate synthase, which is necessary for the synthesis of thymidine, a nucleoside that is essential for DNA replication. By blocking this enzyme, floxuridine can prevent the growth and proliferation of cancer cells.

Floxuridine is often used in combination with other chemotherapy drugs as part of a treatment regimen for colon cancer. It may be administered intravenously or via continuous infusion, depending on the specific treatment plan. As with all chemotherapy drugs, floxuridine can have significant side effects, including nausea, vomiting, diarrhea, and myelosuppression (suppression of bone marrow function), which can lead to anemia, neutropenia, and thrombocytopenia.

Deoxyribonucleosides are chemical compounds that constitute the basic building blocks of DNA, one of the two nucleic acids found in cells. They consist of a sugar molecule called deoxyribose, a nitrogenous base (either adenine, guanine, cytosine, or thymine), and a phosphate group.

The nitrogenous base is attached to the 1' carbon atom of the deoxyribose sugar, forming a glycosidic bond. The phosphate group is linked to the 5' carbon atom of the deoxyribose sugar through an ester linkage, creating a phosphodiester bond with another deoxyribonucleoside.

When multiple deoxyribonucleosides are joined together through their phosphate groups, they form a polynucleotide chain, which is the backbone of DNA. The sequence of nitrogenous bases along this chain encodes genetic information that determines the characteristics and functions of living organisms.

Deoxyribonucleosides play a crucial role in various biological processes, including DNA replication, repair, and transcription. They are also used as therapeutic agents for the treatment of certain genetic disorders and cancer.

Thymidine is a pyrimidine nucleoside that consists of a thymine base linked to a deoxyribose sugar by a β-N1-glycosidic bond. It plays a crucial role in DNA replication and repair processes as one of the four nucleosides in DNA, along with adenosine, guanosine, and cytidine. Thymidine is also used in research and clinical settings for various purposes, such as studying DNA synthesis or as a component of antiviral and anticancer therapies.

Ribonucleosides are organic compounds that consist of a nucleoside bound to a ribose sugar. Nucleosides are formed when a nitrogenous base (such as adenine, guanine, uracil, cytosine, or thymine) is attached to a sugar molecule (either ribose or deoxyribose) via a beta-glycosidic bond. In the case of ribonucleosides, the sugar component is D-ribose. Ribonucleosides play important roles in various biological processes, particularly in the storage, transfer, and expression of genetic information within cells. When ribonucleosides are phosphorylated, they become the building blocks of RNA (ribonucleic acid), a crucial biomolecule involved in protein synthesis and other cellular functions. Examples of ribonucleosides include adenosine, guanosine, uridine, cytidine, and inosine.

Thymidine phosphorylase (TP) is an enzyme that plays a role in the metabolism of nucleosides, specifically thymidine. The medical definition of thymidine phosphorylase is:

An enzyme that catalyzes the conversion of thymidine to thymine and deoxyribose-1-phosphate. Thymidine phosphorylase has been identified as a key enzyme in the angiogenic (formation of new blood vessels) pathway, where it facilitates the release of pro-angiogenic factors such as vascular endothelial growth factor (VEGF).

In addition to its role in nucleoside metabolism and angiogenesis, thymidine phosphorylase has been implicated in cancer biology. Increased levels of thymidine phosphorylase have been found in various human cancers, including colorectal, breast, lung, and pancreatic cancers. These high levels of thymidine phosphorylase are associated with poor prognosis and increased angiogenesis, contributing to tumor growth and metastasis.

Thus, thymidine phosphorylase is a crucial enzyme in nucleoside metabolism, angiogenesis, and cancer biology, making it an important target for the development of novel anti-cancer therapies.

Thymidine kinase (TK) is an enzyme that plays a crucial role in the synthesis of thymidine triphosphate (dTMP), a nucleotide required for DNA replication and repair. It catalyzes the phosphorylation of thymidine to thymidine monophosphate (dTMP) by transferring a phosphate group from adenosine triphosphate (ATP).

There are two major isoforms of thymidine kinase in humans: TK1 and TK2. TK1 is primarily found in the cytoplasm of proliferating cells, such as those involved in the cell cycle, while TK2 is located mainly in the mitochondria and is responsible for maintaining the dNTP pool required for mtDNA replication and repair.

Thymidine kinase activity has been used as a marker for cell proliferation, particularly in cancer cells, which often exhibit elevated levels of TK1 due to their high turnover rates. Additionally, measuring TK1 levels can help monitor the effectiveness of certain anticancer therapies that target DNA replication.

Equilibrative Nucleoside Transporter 2 (ENT2) is a type of protein found in the cell membrane that facilitates the bidirectional transport of nucleosides, which are the building blocks of DNA and RNA, between the intracellular and extracellular spaces. ENT2 is a member of the solute carrier 29 (SLC29) family of transporters and is widely expressed in various tissues, including the brain, liver, kidney, and intestine.

ENT2 plays an essential role in maintaining nucleoside homeostasis by regulating their uptake and efflux across the cell membrane. It has a high affinity for purine nucleosides such as adenosine and guanosine, and to a lesser extent, pyrimidine nucleosides such as uridine and thymidine. The activity of ENT2 is critical in regulating extracellular adenosine levels, which have important implications for various physiological processes, including neurotransmission, inflammation, and cancer.

In addition to its role in nucleoside transport, ENT2 has been implicated in the development of drug resistance in cancer cells. Certain chemotherapeutic agents, such as nucleoside analogs, utilize ENT2 for their uptake into cells. However, overexpression of ENT2 in cancer cells can lead to increased efflux of these drugs, resulting in reduced intracellular concentrations and decreased therapeutic effectiveness. Therefore, ENT2 is an attractive target for the development of novel strategies to overcome drug resistance in cancer therapy.

Hymenolepis is a genus of tapeworms that are commonly found in rodents and other small mammals, but can also infect humans. The two species that are most relevant to human health are Hymenolepis nana and Hymenolepis diminuta.

Hymenolepis nana, also known as the dwarf tapeworm, is the smallest tapeworm that infects humans. It is unique among tapeworms because it can complete its entire life cycle within a single host, without needing an intermediate host. This means that it can be transmitted directly from person to person through contaminated food or water.

Hymenolepis diminuta, on the other hand, requires an intermediate host, such as a beetle or grain moth, to complete its life cycle. Humans can become infected by accidentally ingesting these insects, which may be found in contaminated grains or other food products.

Both species of Hymenolepis can cause similar symptoms in humans, including abdominal pain, diarrhea, and weight loss. In severe cases, they can also lead to more serious complications such as intestinal obstruction or nutritional deficiencies.

It's worth noting that while Hymenolepis infections are not uncommon in certain parts of the world, they are relatively rare in developed countries with good sanitation and hygiene practices. Treatment typically involves taking medication to kill the tapeworms, such as niclosamide or praziquantel.

Trifluridine is an antiviral medication that is primarily used to treat herpetic keratitis, which is a viral infection of the eye caused by the herpes simplex virus. It works by interfering with the replication of the virus's DNA, thereby preventing it from multiplying and causing further damage to the eye.

Trifluridine is available as an ophthalmic solution (eye drops) and is typically applied directly to the affected eye every 2 hours while awake, for a total of 9 doses per day. The treatment period usually lasts for up to 14 days or until the symptoms have resolved.

It's important to note that trifluridine is not used to treat other forms of herpes simplex infections, such as cold sores or genital herpes, and should only be used under the supervision of a healthcare professional.

Uracil is not a medical term, but it is a biological molecule. Medically or biologically, uracil can be defined as one of the four nucleobases in the nucleic acid of RNA (ribonucleic acid) that is linked to a ribose sugar by an N-glycosidic bond. It forms base pairs with adenine in double-stranded RNA and DNA. Uracil is a pyrimidine derivative, similar to thymine found in DNA, but it lacks the methyl group (-CH3) that thymine has at the 5 position of its ring.

Uracil nucleotides are chemical compounds that play a crucial role in the synthesis, repair, and replication of DNA and RNA. Specifically, uracil nucleotides refer to the group of molecules that contain the nitrogenous base uracil, which is linked to a ribose sugar through a beta-glycosidic bond. This forms the nucleoside uridine, which can then be phosphorylated to create the uracil nucleotide.

Uracil nucleotides are important in the formation of RNA, where uracil base pairs with adenine through two hydrogen bonds during transcription. However, uracil is not typically found in DNA, and its presence in DNA can indicate damage or mutation. When uracil is found in DNA, it is usually the result of a process called deamination, where the nitrogenous base cytosine is spontaneously converted to uracil. This can lead to errors during replication, as uracil will pair with adenine instead of guanine, leading to a C-to-T or G-to-A mutation.

To prevent this type of mutation, cells have enzymes called uracil DNA glycosylases that recognize and remove uracil from DNA. This initiates the base excision repair pathway, which removes the damaged nucleotide and replaces it with a correct one. Overall, uracil nucleotides are essential for proper cellular function, but their misincorporation into DNA can have serious consequences for genome stability.

Heterocyclic compounds are organic molecules that contain a ring structure made up of at least one atom that is not carbon, known as a heteroatom. These heteroatoms can include nitrogen, oxygen, sulfur, or other elements. In the case of "2-ring" heterocyclic compounds, the molecule contains two separate ring structures, each of which includes at least one heteroatom.

The term "heterocyclic compound" is used to describe a broad class of organic molecules that are found in many natural and synthetic substances. They play important roles in biology, medicine, and materials science. Heterocyclic compounds can be classified based on the number of rings they contain, as well as the types and arrangements of heteroatoms within those rings.

Two-ring heterocyclic compounds can exhibit a wide range of chemical and physical properties, depending on the nature of the rings and the heteroatoms present. Some examples of two-ring heterocyclic compounds include quinoline, isoquinoline, benzothiazole, and benzoxazole, among many others. These compounds have important applications in pharmaceuticals, dyes, pigments, and other industrial products.

Purines are heterocyclic aromatic organic compounds that consist of a pyrimidine ring fused to an imidazole ring. They are fundamental components of nucleotides, which are the building blocks of DNA and RNA. In the body, purines can be synthesized endogenously or obtained through dietary sources such as meat, seafood, and certain vegetables.

Once purines are metabolized, they are broken down into uric acid, which is excreted by the kidneys. Elevated levels of uric acid in the body can lead to the formation of uric acid crystals, resulting in conditions such as gout or kidney stones. Therefore, maintaining a balanced intake of purine-rich foods and ensuring proper kidney function are essential for overall health.

Tubercidin is not a medical term itself, but it is a type of antibiotic that belongs to the class of compounds known as nucleoside antibiotics. Specifically, tubercidin is a naturally occurring adenine analogue that is produced by several species of Streptomyces bacteria.

Tubercidin has been found to have antimicrobial and antitumor activities. It works by inhibiting the enzyme adenosine deaminase, which plays a crucial role in the metabolism of nucleotides in cells. By inhibiting this enzyme, tubercidin can interfere with DNA and RNA synthesis, leading to cell death.

While tubercidin has shown promise as an anticancer agent in preclinical studies, its clinical use is limited due to its toxicity and potential for causing mutations in normal cells. Therefore, it is primarily used for research purposes to study the mechanisms of nucleotide metabolism and the effects of nucleoside analogues on cell growth and differentiation.

Nucleoside-phosphate kinase (NPK) is an enzyme that plays a crucial role in the synthesis and metabolism of nucleotides, which are the building blocks of DNA and RNA. NPK catalyzes the transfer of a phosphate group from a donor molecule, typically ATP, to a nucleoside or deoxynucleoside, forming a nucleoside monophosphate (NMP) or deoxynucleoside monophosphate (dNMP).

There are several isoforms of NPK found in different cellular compartments and tissues, each with distinct substrate specificities. These enzymes play essential roles in maintaining the balance of nucleotides required for various cellular processes, including DNA replication, repair, and transcription, as well as RNA synthesis and metabolism.

Abnormalities in NPK activity or expression have been implicated in several human diseases, such as cancer, viral infections, and neurological disorders. Therefore, understanding the function and regulation of NPK is crucial for developing novel therapeutic strategies to target these conditions.

Nucleotides are the basic structural units of nucleic acids, such as DNA and RNA. They consist of a nitrogenous base (adenine, guanine, cytosine, thymine or uracil), a pentose sugar (ribose in RNA and deoxyribose in DNA) and one to three phosphate groups. Nucleotides are linked together by phosphodiester bonds between the sugar of one nucleotide and the phosphate group of another, forming long chains known as polynucleotides. The sequence of these nucleotides determines the genetic information carried in DNA and RNA, which is essential for the functioning, reproduction and survival of all living organisms.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Equilibrative nucleoside transport proteins (ENTs) are a type of membrane transporter that regulate the bidirectional movement of nucleosides across the cell membrane. They facilitate the diffusion of nucleosides down their concentration gradient, hence the term "equilibrative." These transport proteins play a crucial role in maintaining intracellular nucleoside concentrations and ensuring proper nucleotide synthesis for various cellular processes, including DNA replication, repair, and gene expression. There are two major families of ENTs: the human equilibrative nucleoside transporters (hENTs) and the concentrative nucleoside transporters (CNTs). The hENT family includes four members (hENT1-4), while the CNT family consists of three members (CNT1-3). These transport proteins have been identified as potential targets for cancer therapy, as inhibiting their function can selectively sensitize tumor cells to nucleoside analog-based chemotherapies.

Hypoxanthine is not a medical condition but a purine base that is a component of many organic compounds, including nucleotides and nucleic acids, which are the building blocks of DNA and RNA. In the body, hypoxanthine is produced as a byproduct of normal cellular metabolism and is converted to xanthine and then uric acid, which is excreted in the urine.

However, abnormally high levels of hypoxanthine in the body can indicate tissue damage or disease. For example, during intense exercise or hypoxia (low oxygen levels), cells may break down ATP (adenosine triphosphate) rapidly, releasing large amounts of hypoxanthine. Similarly, in some genetic disorders such as Lesch-Nyhan syndrome, there is an accumulation of hypoxanthine due to a deficiency of the enzyme that converts it to xanthine. High levels of hypoxanthine can lead to the formation of kidney stones and other complications.

Adenosine is a purine nucleoside that is composed of a sugar (ribose) and the base adenine. It plays several important roles in the body, including serving as a precursor for the synthesis of other molecules such as ATP, NAD+, and RNA.

In the medical context, adenosine is perhaps best known for its use as a pharmaceutical agent to treat certain cardiac arrhythmias. When administered intravenously, it can help restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT) by slowing conduction through the atrioventricular node and interrupting the reentry circuit responsible for the arrhythmia.

Adenosine can also be used as a diagnostic tool to help differentiate between narrow-complex tachycardias of supraventricular origin and those that originate from below the ventricles (such as ventricular tachycardia). This is because adenosine will typically terminate PSVT but not affect the rhythm of VT.

It's worth noting that adenosine has a very short half-life, lasting only a few seconds in the bloodstream. This means that its effects are rapidly reversible and generally well-tolerated, although some patients may experience transient symptoms such as flushing, chest pain, or shortness of breath.

Antiviral agents are a class of medications that are designed to treat infections caused by viruses. Unlike antibiotics, which target bacteria, antiviral agents interfere with the replication and infection mechanisms of viruses, either by inhibiting their ability to replicate or by modulating the host's immune response to the virus.

Antiviral agents are used to treat a variety of viral infections, including influenza, herpes simplex virus (HSV) infections, human immunodeficiency virus (HIV) infection, hepatitis B and C, and respiratory syncytial virus (RSV) infections.

These medications can be administered orally, intravenously, or topically, depending on the type of viral infection being treated. Some antiviral agents are also used for prophylaxis, or prevention, of certain viral infections.

It is important to note that antiviral agents are not effective against all types of viruses and may have significant side effects. Therefore, it is essential to consult with a healthcare professional before starting any antiviral therapy.

Phosphotransferases are a group of enzymes that catalyze the transfer of a phosphate group from a donor molecule to an acceptor molecule. This reaction is essential for various cellular processes, including energy metabolism, signal transduction, and biosynthesis.

The systematic name for this group of enzymes is phosphotransferase, which is derived from the general reaction they catalyze: D-donor + A-acceptor = D-donor minus phosphate + A-phosphate. The donor molecule can be a variety of compounds, such as ATP or a phosphorylated protein, while the acceptor molecule is typically a compound that becomes phosphorylated during the reaction.

Phosphotransferases are classified into several subgroups based on the type of donor and acceptor molecules they act upon. For example, kinases are a subgroup of phosphotransferases that transfer a phosphate group from ATP to a protein or other organic compound. Phosphatases, another subgroup, remove phosphate groups from molecules by transferring them to water.

Overall, phosphotransferases play a critical role in regulating many cellular functions and are important targets for drug development in various diseases, including cancer and neurological disorders.

Substrate specificity in the context of medical biochemistry and enzymology refers to the ability of an enzyme to selectively bind and catalyze a chemical reaction with a particular substrate (or a group of similar substrates) while discriminating against other molecules that are not substrates. This specificity arises from the three-dimensional structure of the enzyme, which has evolved to match the shape, charge distribution, and functional groups of its physiological substrate(s).

Substrate specificity is a fundamental property of enzymes that enables them to carry out highly selective chemical transformations in the complex cellular environment. The active site of an enzyme, where the catalysis takes place, has a unique conformation that complements the shape and charge distribution of its substrate(s). This ensures efficient recognition, binding, and conversion of the substrate into the desired product while minimizing unwanted side reactions with other molecules.

Substrate specificity can be categorized as:

1. Absolute specificity: An enzyme that can only act on a single substrate or a very narrow group of structurally related substrates, showing no activity towards any other molecule.
2. Group specificity: An enzyme that prefers to act on a particular functional group or class of compounds but can still accommodate minor structural variations within the substrate.
3. Broad or promiscuous specificity: An enzyme that can act on a wide range of structurally diverse substrates, albeit with varying catalytic efficiencies.

Understanding substrate specificity is crucial for elucidating enzymatic mechanisms, designing drugs that target specific enzymes or pathways, and developing biotechnological applications that rely on the controlled manipulation of enzyme activities.

Dipyridamole is a medication that belongs to a class of drugs called antiplatelet agents. It works by preventing platelets in your blood from sticking together to form clots. Dipyridamole is often used in combination with aspirin to prevent stroke and other complications in people who have had a heart valve replacement or a type of irregular heartbeat called atrial fibrillation.

Dipyridamole can also be used as a stress agent in myocardial perfusion imaging studies, which are tests used to evaluate blood flow to the heart. When used for this purpose, dipyridamole is given intravenously and works by dilating the blood vessels in the heart, allowing more blood to flow through them and making it easier to detect areas of reduced blood flow.

The most common side effects of dipyridamole include headache, dizziness, and gastrointestinal symptoms such as diarrhea, nausea, and vomiting. In rare cases, dipyridamole can cause more serious side effects, such as allergic reactions, abnormal heart rhythms, or low blood pressure. It is important to take dipyridamole exactly as directed by your healthcare provider and to report any unusual symptoms or side effects promptly.

Purine-nucleoside phosphorylase (PNP) is an enzyme that plays a crucial role in the metabolism of purines, which are essential components of nucleic acids (DNA and RNA). The medical definition of 'Purine-Nucleoside Phosphorylase' refers to the physiological function of this enzyme in the human body.

PNP is responsible for catalyzing the phosphorolytic cleavage of purine nucleosides, such as inosine and guanosine, into their respective purine bases (hypoxanthine and guanine) and ribose-1-phosphate. This reaction is essential for the recycling and salvage of purine bases, allowing the body to conserve energy and resources needed for de novo purine biosynthesis.

In a clinical or medical context, deficiencies in PNP activity can lead to serious consequences, particularly affecting the immune system and the nervous system. A genetic disorder called Purine-Nucleoside Phosphorylase Deficiency (PNP Deficiency) is characterized by significantly reduced or absent PNP enzyme activity, leading to an accumulation of toxic purine nucleosides and deoxypurine nucleosides. This accumulation can cause severe combined immunodeficiency (SCID), neurological impairments, and other complications, making it a critical area of study in medical research.

A Structure-Activity Relationship (SAR) in the context of medicinal chemistry and pharmacology refers to the relationship between the chemical structure of a drug or molecule and its biological activity or effect on a target protein, cell, or organism. SAR studies aim to identify patterns and correlations between structural features of a compound and its ability to interact with a specific biological target, leading to a desired therapeutic response or undesired side effects.

By analyzing the SAR, researchers can optimize the chemical structure of lead compounds to enhance their potency, selectivity, safety, and pharmacokinetic properties, ultimately guiding the design and development of novel drugs with improved efficacy and reduced toxicity.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Membrane transport proteins are specialized biological molecules, specifically integral membrane proteins, that facilitate the movement of various substances across the lipid bilayer of cell membranes. They are responsible for the selective and regulated transport of ions, sugars, amino acids, nucleotides, and other molecules into and out of cells, as well as within different cellular compartments. These proteins can be categorized into two main types: channels and carriers (or pumps). Channels provide a passive transport mechanism, allowing ions or small molecules to move down their electrochemical gradient, while carriers actively transport substances against their concentration gradient, requiring energy usually in the form of ATP. Membrane transport proteins play a crucial role in maintaining cell homeostasis, signaling processes, and many other physiological functions.

Inosine is not a medical condition but a naturally occurring compound called a nucleoside, which is formed from the combination of hypoxanthine and ribose. It is an intermediate in the metabolic pathways of purine nucleotides, which are essential components of DNA and RNA. Inosine has been studied for its potential therapeutic benefits in various medical conditions, including neurodegenerative disorders, cardiovascular diseases, and cancer. However, more research is needed to fully understand its mechanisms and clinical applications.

Molecular structure, in the context of biochemistry and molecular biology, refers to the arrangement and organization of atoms and chemical bonds within a molecule. It describes the three-dimensional layout of the constituent elements, including their spatial relationships, bond lengths, and angles. Understanding molecular structure is crucial for elucidating the functions and reactivities of biological macromolecules such as proteins, nucleic acids, lipids, and carbohydrates. Various experimental techniques, like X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy (cryo-EM), are employed to determine molecular structures at atomic resolution, providing valuable insights into their biological roles and potential therapeutic targets.

Deoxycytidine is a chemical compound that is a component of DNA, one of the nucleic acids in living organisms. It is a nucleoside, consisting of the sugar deoxyribose and the base cytosine. Deoxycytidine pairs with guanine via hydrogen bonds to form base pairs in the double helix structure of DNA.

In biochemistry, deoxycytidine can also exist as a free nucleoside, not bound to other molecules. It is involved in various cellular processes related to DNA metabolism and replication. Deoxycytidine can be phosphorylated to form deoxycytidine monophosphate (dCMP), which is an important intermediate in the synthesis of DNA.

It's worth noting that while deoxycytidine is a component of DNA, its counterpart in RNA is cytidine, which contains ribose instead of deoxyribose as the sugar component.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Nucleoside-diphosphate kinase (NDK) is an enzyme that plays a crucial role in the regulation of intracellular levels of nucleoside triphosphates and diphosphates. These nucleotides are essential for various cellular processes, including DNA replication, transcription, translation, and energy metabolism.

NDK catalyzes the transfer of a phosphate group from a nucleoside triphosphate (most commonly ATP or GTP) to a nucleoside diphosphate (NDP), converting it into a nucleoside triphosphate (NTP). The reaction can be summarized as follows:

NTP + NDP ↔ NDP + NTP

The enzyme has several isoforms, which are differentially expressed in various tissues and cellular compartments. In humans, there are nine known isoforms of NDK, classified into three subfamilies: NM23-H (NME1), NM23-H2 (NME2), and NME4-8. These isoforms share a conserved catalytic core but differ in their regulatory domains and cellular localization.

NDK has been implicated in several physiological processes, such as cell proliferation, differentiation, and survival. Dysregulation of NDK activity has been associated with various pathological conditions, including cancer, neurodegenerative diseases, and viral infections.

Deoxyribonucleic acid (DNA) is the genetic material present in the cells of organisms where it is responsible for the storage and transmission of hereditary information. DNA is a long molecule that consists of two strands coiled together to form a double helix. Each strand is made up of a series of four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - that are linked together by phosphate and sugar groups. The sequence of these bases along the length of the molecule encodes genetic information, with A always pairing with T and C always pairing with G. This base-pairing allows for the replication and transcription of DNA, which are essential processes in the functioning and reproduction of all living organisms.

Orotic acid, also known as pyrmidine carboxylic acid, is a organic compound that plays a role in the metabolic pathway for the biosynthesis of pyrimidines, which are nitrogenous bases found in nucleotides and nucleic acids such as DNA and RNA. Orotic acid is not considered to be a vitamin, but it is sometimes referred to as vitamin B13 or B15, although these designations are not widely recognized by the scientific community.

In the body, orotic acid is converted into orotidine monophosphate (OMP) by the enzyme orotate phosphoribosyltransferase. OMP is then further metabolized to form uridine monophosphate (UMP), a pyrimidine nucleotide that is an important precursor for the synthesis of RNA and other molecules.

Elevated levels of orotic acid in the urine, known as orotic aciduria, can be a sign of certain genetic disorders that affect the metabolism of pyrimidines. These conditions can lead to an accumulation of orotic acid and other pyrimidine precursors in the body, which can cause a range of symptoms including developmental delays, neurological problems, and kidney stones. Treatment for these disorders typically involves dietary restrictions and supplementation with nucleotides or nucleosides to help support normal pyrimidine metabolism.

Biological transport refers to the movement of molecules, ions, or solutes across biological membranes or through cells in living organisms. This process is essential for maintaining homeostasis, regulating cellular functions, and enabling communication between cells. There are two main types of biological transport: passive transport and active transport.

Passive transport does not require the input of energy and includes:

1. Diffusion: The random movement of molecules from an area of high concentration to an area of low concentration until equilibrium is reached.
2. Osmosis: The diffusion of solvent molecules (usually water) across a semi-permeable membrane from an area of lower solute concentration to an area of higher solute concentration.
3. Facilitated diffusion: The assisted passage of polar or charged substances through protein channels or carriers in the cell membrane, which increases the rate of diffusion without consuming energy.

Active transport requires the input of energy (in the form of ATP) and includes:

1. Primary active transport: The direct use of ATP to move molecules against their concentration gradient, often driven by specific transport proteins called pumps.
2. Secondary active transport: The coupling of the movement of one substance down its electrochemical gradient with the uphill transport of another substance, mediated by a shared transport protein. This process is also known as co-transport or counter-transport.

Purine nucleotides are fundamental units of life that play crucial roles in various biological processes. A purine nucleotide is a type of nucleotide, which is the basic building block of nucleic acids such as DNA and RNA. Nucleotides consist of a nitrogenous base, a pentose sugar, and at least one phosphate group.

In purine nucleotides, the nitrogenous bases are either adenine (A) or guanine (G). These bases are attached to a five-carbon sugar called ribose in the case of RNA or deoxyribose for DNA. The sugar and base together form the nucleoside, while the addition of one or more phosphate groups creates the nucleotide.

Purine nucleotides have several vital functions within cells:

1. Energy currency: Adenosine triphosphate (ATP) is a purine nucleotide that serves as the primary energy currency in cells, storing and transferring chemical energy for various cellular processes.
2. Genetic material: Both DNA and RNA contain purine nucleotides as essential components of their structures. Adenine pairs with thymine (in DNA) or uracil (in RNA), while guanine pairs with cytosine.
3. Signaling molecules: Purine nucleotides, such as adenosine monophosphate (AMP) and cyclic adenosine monophosphate (cAMP), act as intracellular signaling molecules that regulate various cellular functions, including metabolism, gene expression, and cell growth.
4. Coenzymes: Purine nucleotides can also function as coenzymes, assisting enzymes in catalyzing biochemical reactions. For example, nicotinamide adenine dinucleotide (NAD+) is a purine nucleotide that plays a critical role in redox reactions and energy metabolism.

In summary, purine nucleotides are essential biological molecules involved in various cellular functions, including energy transfer, genetic material formation, intracellular signaling, and enzyme cofactor activity.

According to the medical definition, ultraviolet (UV) rays are invisible radiations that fall in the range of the electromagnetic spectrum between 100-400 nanometers. UV rays are further divided into three categories: UVA (320-400 nm), UVB (280-320 nm), and UVC (100-280 nm).

UV rays have various sources, including the sun and artificial sources like tanning beds. Prolonged exposure to UV rays can cause damage to the skin, leading to premature aging, eye damage, and an increased risk of skin cancer. UVA rays penetrate deeper into the skin and are associated with skin aging, while UVB rays primarily affect the outer layer of the skin and are linked to sunburns and skin cancer. UVC rays are the most harmful but fortunately, they are absorbed by the Earth's atmosphere and do not reach the surface.

Healthcare professionals recommend limiting exposure to UV rays, wearing protective clothing, using broad-spectrum sunscreen with an SPF of at least 30, and avoiding tanning beds to reduce the risk of UV-related health problems.

Medical Definition of "Herpesvirus 1, Human" (also known as Human Herpesvirus 1 or HHV-1):

Herpesvirus 1, Human is a type of herpesvirus that primarily causes infection in humans. It is also commonly referred to as human herpesvirus 1 (HHV-1) or oral herpes. This virus is highly contagious and can be transmitted through direct contact with infected saliva, skin, or mucous membranes.

After initial infection, the virus typically remains dormant in the body's nerve cells and may reactivate later, causing recurrent symptoms. The most common manifestation of HHV-1 infection is oral herpes, characterized by cold sores or fever blisters around the mouth and lips. In some cases, HHV-1 can also cause other conditions such as encephalitis (inflammation of the brain) and keratitis (inflammation of the eye's cornea).

There is no cure for HHV-1 infection, but antiviral medications can help manage symptoms and reduce the severity and frequency of recurrent outbreaks.

Magnetic Resonance Spectroscopy (MRS) is a non-invasive diagnostic technique that provides information about the biochemical composition of tissues, including their metabolic state. It is often used in conjunction with Magnetic Resonance Imaging (MRI) to analyze various metabolites within body tissues, such as the brain, heart, liver, and muscles.

During MRS, a strong magnetic field, radio waves, and a computer are used to produce detailed images and data about the concentration of specific metabolites in the targeted tissue or organ. This technique can help detect abnormalities related to energy metabolism, neurotransmitter levels, pH balance, and other biochemical processes, which can be useful for diagnosing and monitoring various medical conditions, including cancer, neurological disorders, and metabolic diseases.

There are different types of MRS, such as Proton (^1^H) MRS, Phosphorus-31 (^31^P) MRS, and Carbon-13 (^13^C) MRS, each focusing on specific elements or metabolites within the body. The choice of MRS technique depends on the clinical question being addressed and the type of information needed for diagnosis or monitoring purposes.

Orotate phosphoribosyltransferase (OPRT) is an enzyme that catalyzes the conversion of orotate to oximine monophosphate (OMP), which is a key step in the biosynthesis of pyrimidines, a type of nucleotide. This enzyme plays a crucial role in the metabolism of nucleic acids, which are the building blocks of DNA and RNA.

The reaction catalyzed by OPRT is as follows:

orotate + phosphoribosyl pyrophosphate (PRPP) -> oximine monophosphate (OMP) + pyrophosphate

Defects in the gene that encodes for OPRT can lead to orotic aciduria, a rare genetic disorder characterized by an accumulation of orotic acid and other pyrimidines in the urine and other body fluids. Symptoms of this condition may include developmental delay, mental retardation, seizures, and megaloblastic anemia.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Carrier proteins, also known as transport proteins, are a type of protein that facilitates the movement of molecules across cell membranes. They are responsible for the selective and active transport of ions, sugars, amino acids, and other molecules from one side of the membrane to the other, against their concentration gradient. This process requires energy, usually in the form of ATP (adenosine triphosphate).

Carrier proteins have a specific binding site for the molecule they transport, and undergo conformational changes upon binding, which allows them to move the molecule across the membrane. Once the molecule has been transported, the carrier protein returns to its original conformation, ready to bind and transport another molecule.

Carrier proteins play a crucial role in maintaining the balance of ions and other molecules inside and outside of cells, and are essential for many physiological processes, including nerve impulse transmission, muscle contraction, and nutrient uptake.

Formycins are a group of antibiotics that are derived from certain strains of Streptomyces bacteria. They include formycin B (also known as pyrazofurin), which is an antiviral and antimetabolite drug that works by interfering with the production of genetic material in cells. Formycins are not widely used in clinical medicine due to their potential toxicity and the availability of other effective antibiotics and antiviral drugs.

I'm sorry for any confusion, but "Nucleoside Q" is not a recognized or established term in medical or biological nomenclature. Nucleosides are organic molecules consisting of a pentose sugar (ribose or deoxyribose) linked to a nitrogenous base (adenine, guanine, cytosine, thymine, or uracil). There is no "Q" nucleoside in the standard nomenclature.

If you have any questions about specific nucleosides or related compounds, I'd be happy to try and help clarify those for you!

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Adenine is a purine nucleotide base that is a fundamental component of DNA and RNA, the genetic material of living organisms. In DNA, adenine pairs with thymine via double hydrogen bonds, while in RNA, it pairs with uracil. Adenine is essential for the structure and function of nucleic acids, as well as for energy transfer reactions in cells through its role in the formation of adenosine triphosphate (ATP), the primary energy currency of the cell.

Nucleoside-triphosphatase (NTPase) is not a medical term per se, but rather a biochemical term. However, it is often used in the context of molecular biology and genetics, which are essential components of medical research and practice. Therefore, I will provide a definition related to these fields.

Nucleoside-triphosphatase (NTPase) refers to an enzyme that catalyzes the hydrolysis of nucleoside triphosphates (NTPs) into nucleoside diphosphates (NDPs) and inorganic phosphate (Pi). NTPs, such as adenosine triphosphate (ATP), guanosine triphosphate (GTP), cytidine triphosphate (CTP), and uridine triphosphate (UTP), are crucial for energy transfer in cells.

In the context of molecular biology, NTPases play essential roles in various cellular processes, including DNA replication, transcription, translation, and degradation. For example, DNA polymerase, an enzyme involved in DNA replication, is a type of NTPase that utilizes dNTPs (deoxynucleoside triphosphates) to synthesize new DNA strands. Similarly, RNA polymerase, which catalyzes the transcription of DNA into RNA, uses NTPs as substrates and has NTPase activity.

In summary, Nucleoside-triphosphatase (NTPase) is an enzyme that hydrolyzes nucleoside triphosphates (NTPs), releasing energy and playing a critical role in various cellular processes, including DNA replication, transcription, translation, and degradation.

Dihydroorotase is an enzyme that plays a crucial role in the synthesis of pyrimidines, which are essential components of nucleic acids such as DNA and RNA. Specifically, dihydroorotase catalyzes the conversion of N-carbamoyl-L-aspartate into L-dihydroorotate and L-carbamoyl aspartate in the third step of de novo pyrimidine biosynthesis.

The reaction catalyzed by dihydroorotase is:

N-carbamoyl-L-aspartate + H2O → L-dihydroorotate + L-carbamoyl aspartate

Dihydroorotase is a member of the amidohydrolase superfamily and functions as a homodimer or homotetramer. In humans, dihydroorotase is encoded by the DHODH gene and is found in the cytoplasm of cells. Defects in this enzyme can lead to a rare genetic disorder called dihydropyrimidine dehydrogenase deficiency, which is characterized by an accumulation of pyrimidines and their precursors in the body.

Deoxyribodipyrimidine photo-lyase is an enzyme involved in the repair of DNA damage, specifically the repair of cyclobutane pyrimidine dimers (CPDs) that are formed when DNA is exposed to ultraviolet (UV) light. CPDs can distort the structure of DNA and interfere with replication and transcription, so it's important for cells to have mechanisms to repair this damage.

Deoxyribodipyrimidine photo-lyase works by cleaving the bond between two adjacent pyrimidines in the DNA strand that form the CPD, releasing one of the pyrimidines and allowing the remaining portion of the strand to be repaired. This enzyme is also known as photolyase or DNA repair photolyase.

It's worth noting that there are different types of photolyases that can repair different kinds of DNA damage, but deoxyribodipyrimidine photo-lyase specifically repairs CPDs caused by UV light.

A cell line is a culture of cells that are grown in a laboratory for use in research. These cells are usually taken from a single cell or group of cells, and they are able to divide and grow continuously in the lab. Cell lines can come from many different sources, including animals, plants, and humans. They are often used in scientific research to study cellular processes, disease mechanisms, and to test new drugs or treatments. Some common types of human cell lines include HeLa cells (which come from a cancer patient named Henrietta Lacks), HEK293 cells (which come from embryonic kidney cells), and HUVEC cells (which come from umbilical vein endothelial cells). It is important to note that cell lines are not the same as primary cells, which are cells that are taken directly from a living organism and have not been grown in the lab.

Hydrogen-ion concentration, also known as pH, is a measure of the acidity or basicity of a solution. It is defined as the negative logarithm (to the base 10) of the hydrogen ion activity in a solution. The standard unit of measurement is the pH unit. A pH of 7 is neutral, less than 7 is acidic, and greater than 7 is basic.

In medical terms, hydrogen-ion concentration is important for maintaining homeostasis within the body. For example, in the stomach, a high hydrogen-ion concentration (low pH) is necessary for the digestion of food. However, in other parts of the body such as blood, a high hydrogen-ion concentration can be harmful and lead to acidosis. Conversely, a low hydrogen-ion concentration (high pH) in the blood can lead to alkalosis. Both acidosis and alkalosis can have serious consequences on various organ systems if not corrected.

Aspartate carbamoyltransferase (ACT) is a crucial enzyme in the urea cycle, which is the biochemical pathway responsible for the elimination of excess nitrogen waste from the body. This enzyme catalyzes the second step of the urea cycle, where it facilitates the transfer of a carbamoyl group from carbamoyl phosphate to aspartic acid, forming N-acetylglutamic semialdehyde and releasing phosphate in the process.

The reaction catalyzed by aspartate carbamoyltransferase is as follows:

Carbamoyl phosphate + L-aspartate → N-acetylglutamic semialdehyde + P\_i + CO\_2

This enzyme plays a critical role in maintaining nitrogen balance and preventing the accumulation of toxic levels of ammonia in the body. Deficiencies or mutations in aspartate carbamoyltransferase can lead to serious metabolic disorders, such as citrullinemia and hyperammonemia, which can have severe neurological consequences if left untreated.

Deoxyadenosine is a chemical compound that is a component of DNA, one of the nucleic acids that make up the genetic material of living organisms. Specifically, deoxyadenosine is a nucleoside, which is a molecule consisting of a sugar (in this case, deoxyribose) bonded to a nitrogenous base (in this case, adenine).

Deoxyribonucleosides like deoxyadenosine are the building blocks of DNA, along with phosphate groups. In DNA, deoxyadenosine pairs with thymidine via hydrogen bonds to form one of the four rungs in the twisted ladder structure of the double helix.

It is important to note that there is a similar compound called adenosine, which contains an extra oxygen atom on the sugar molecule (making it a ribonucleoside) and is a component of RNA, another nucleic acid involved in protein synthesis and other cellular processes.

... a pyrimidine-nucleoside phosphorylase (EC 2.4.2.2) is an enzyme that catalyzes the chemical reaction a pyrimidine nucleoside + ... the two substrates of this enzyme are pyrimidine nucleoside and phosphate, whereas its two products are pyrimidine base and ... "Purification and characterization of purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase from Bacillus ... The systematic name of this enzyme class is pyrimidine-nucleoside:phosphate alpha-D-ribosyltransferase. This enzyme is also ...
Bergstrom DE, Ogawa MK (1978). "C-5 substituted pyrimidine nucleosides. 2. Synthesis via olefin coupling to organopalladium ... Synthesis of C-5 substituted pyrimidine nucleosides via organopalladium intermediates". Journal of the American Chemical ... It is an analog of thymidine, a nucleoside. It has shown effectiveness against herpes simplex virus. Mercuration of the 2'- ...
Pyrimidine nucleosides include cytidine, uridine, and thymidine. The synthesis of any pyrimidine nucleotide begins with the ... The conversion of a nucleoside-diphosphate (NDP) to a nucleoside-triphosphate (NTP) is catalyzed by nucleoside diphosphate ... a pyrimidine nucleotide, is an inhibitor of pyrimidine synthesis. This regulation helps to keep the purine/pyrimidine amounts ... Purine and pyrimidine nucleosides can either be degraded to waste products and excreted or can be salvaged as nucleotide ...
... pyrimidine nucleoside antibiotics. Total synthesis and structure of toyocamycin, unamycin B, vengicide, antibiotic E-212, and ... Sangivamycin is a natural product originally isolated from Streptomyces rimosus, which is a nucleoside analogue. It acts as an ... Loomis CR, Bell RM (February 1988). "Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C". The ... Lee SA, Jung M (May 2007). "The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin ...
Lamivudine is the negative enantiomer and is a pyrimidine nucleoside analogue. The 3' carbon of the ribose ring of 2'- ... Addition of the second phosphate group to nucleoside monophosphate analogues is completed by the nucleoside monophosphate ... Zalcitabine is a synthetic pyrimidine nucleoside analogue, structurally related to deoxycytidine, in which the 3´-hydroxyl ... Many nucleoside analogues were prepared and examined but only one had significant activity and satisfied the requirements for ...
... (CTP) is a pyrimidine nucleoside triphosphate. CTP, much like ATP, consists of a ribose sugar, and three ... CTP acts as an inhibitor of the enzyme aspartate carbamoyltransferase, which is used in pyrimidine biosynthesis. CTP synthase ... Cytidine Cytosine Pyrimidine biosynthesis Buchanan BB, Gruissem W, Jones RL (2000). Biochemistry & molecular biology of plants ...
Saunders PP, Wilson BA, Saunders GF (1969). "Purification and comparative properties of a pyrimidine nucleoside phosphorylase ... Nucleoside phosphorylase is an enzyme which cleaves a nucleoside by phosphorylating the ribose to produce a nucleobase and ... pyrimidine metabolism, and nicotinate and nicotinamide metabolism. Purine nucleoside phosphorylase is an enzyme involved in ... Purine nucleoside phosphorylase, PNP, PNPase or inosine phosphorylase (EC 2.4.2.1) is an enzyme that in humans is encoded by ...
... and Pyrimidine-Derived Nucleosides". Interplay between Metal Ions and Nucleic Acids. Metal Ions in Life Sciences. Vol. 10. pp. ... Purines are complementary only with pyrimidines: pyrimidine-pyrimidine pairings are energetically unfavorable because the ... Purine-pyrimidine base-pairing of AT or GC or UA (in RNA) results in proper duplex structure. The only other purine-pyrimidine ... are members of a class of single-ringed chemical structures called pyrimidines. ...
The systematic name of this enzyme class is nucleoside:purine(pyrimidine) D-ribosyltransferase. This enzyme is also called ... In enzymology, a nucleoside ribosyltransferase (EC 2.4.2.5) is an enzyme that catalyzes the chemical reaction D-ribosyl-base1 ... Koch AL (November 1956). "Some enzymes of nucleoside metabolism of Escherichia coli". The Journal of Biological Chemistry. 223 ...
SLC28A1 is a Na+-dependent nucleoside transporter selective for pyrimidine nucleosides and adenosine. It also transports the ... Human concentrative nucleoside transporters include SLC28A1, SLC28A2 and SLC28A3 proteins. SLC28A2 is a purine-specific Na+- ... nucleoside cotransporter". The Journal of Biological Chemistry. 270 (23): 13596-9. doi:10.1074/jbc.270.23.13596. PMID 7775409. ... "Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein". The Journal of ...
... plays a key role in pyrimidine salvage to recover nucleosides after DNA/RNA degradation. Although the ... Nucleoside: Pyrimidine Deoxyribosyltransferase Activity of Three Partially Purified Thymidine Phosphorylases". The Journal of ... LaFon SW, Nelson DJ, Berens RL, Marr JJ (January 1982). "Purine and pyrimidine salvage pathways in Leishmania donovani". ... Friedkin M, Roberts D (March 1954). "The enzymatic synthesis of nucleosides. I. Thymidine phosphorylase in mammalian tissue". ...
The formation of 2',2'-unsaturated pyrimidine nucleosides via a novel beta-elimination reaction". The Journal of Organic ... Zalcitabine is an analog of pyrimidine. It is a derivative of the naturally existing deoxycytidine, made by replacing the ... Zalcitabine appears less potent than some other nucleoside RTIs, has an inconvenient three-times daily frequency and is ... Horwitz JR, Chua J, Da Rooge MA, Noel M, Klundt IL (January 1966). "Nucleosides. IX. ...
... pyrimidine) deoxy-D-ribosyltransferase. Other names in common use include purine(pyrimidine) nucleoside:purine(pyrimidine) ... pyrimidine), and nucleoside:purine(pyrimidine) deoxyribosyltransferase]. This enzyme participates in pyrimidine metabolism. As ... purine nucleoside:purine, deoxyribosyltransferase: strictly specific for transfer between, purine bases), nucleoside ... In enzymology, a nucleoside deoxyribosyltransferase (EC 2.4.2.6) is an enzyme that catalyzes the chemical reaction 2-deoxy-D- ...
... a pyrimidine base Thus, the two substrates of this enzyme are pyrimidine nucleoside and H2O, whereas its two products are D- ... pyrimidine nucleoside hydrolase, RihB, YeiK, and nucleoside ribohydrolase. This enzyme participates in purine metabolism and ... Giabbai B, Degano M (2004). "Crystal structure to 1.7 a of the Escherichia coli pyrimidine nucleoside hydrolase YeiK, a novel ... The systematic name of this enzyme class is pyrimidine-nucleoside ribohydrolase. Other names in common use include N- ...
Hotchkiss RD (1948). "The quantitative separation of purines, pyrimidines and nucleosides by paper chromatography". J Biol Chem ... 5-Methylcytosine is incorporated in the nucleoside 5-methylcytidine. In 5-methylcytosine, a methyl group is attached to the 5th ...
Nucleoside Nucleotide DNA RNA Oligonucleotide Pyrimidine biosynthesis Lide M, Lide DR (1998). CRC Handbook of Chemistry and ... It is an ester of phosphoric acid with the nucleoside uridine. UMP consists of the phosphate group, the pentose sugar ribose, ...
... (dCTP) is a nucleoside triphosphate that contains the pyrimidine base cytosine. The triphosphate ... Like other nucleoside triphosphates, manufacturers recommend that dCTP be stored in aqueous solution at −20 °C. DNA replication ...
showed how pyrimidine nucleosides can be synthesized from small molecules and ribose, driven solely by wet-dry cycles. Purine ... Although pyrimidine derivatives such as alloxan were known in the early 19th century, a laboratory synthesis of a pyrimidine ... Pyrimidine is also found in meteorites, but scientists still do not know its origin. Pyrimidine also photolytically decomposes ... some minor pyrimidine bases can also occur in nucleic acids. These minor pyrimidines are usually methylated versions of major ...
showed how pyrimidine nucleosides can be synthesized from small molecules and ribose, driven solely by wet-dry cycles. ... Pyrimidine biosynthesis occurs both in the body and through organic synthesis. De Novo biosynthesis of a pyrimidine is ... Pyrimidines are ultimately catabolized (degraded) to CO2, H2O, and urea. Cytosine can be broken down to uracil, which can be ... Pyrimidine synthesis inhibitors are used in active moderate to severe rheumatoid arthritis and psoriatic arthritis, as well as ...
showed how pyrimidine nucleosides can be synthesized from small molecules and ribose, driven solely by wet-dry cycles. Purine ... With all three joined, a nucleotide is also termed a "nucleoside monophosphate", "nucleoside diphosphate" or "nucleoside ... The purine bases adenine and guanine and pyrimidine base cytosine occur in both DNA and RNA, while the pyrimidine bases thymine ... De novo synthesis of pyrimidines and purines follows two different pathways. Pyrimidines are synthesized first from aspartate ...
The chemical compound 3-methyluridine, also called N3-methyluridine, is a pyrimidine nucleoside (abbreviated m3U). In living ... Nucleosides, Pyrimidinediones, All stub articles, Organic compound stubs). ... "Solution conformations of two naturally occurring RNA nucleosides: 3-methyluridine and 3-methylpseudouridine". Bioorganic & ...
Within a cell, pyrimidine nucleoside phosphorylase or thymidine phosphorylase can metabolize doxifluridine into 5-FU. It is ... High levels of pyrimidine-nucleoside phosphorylase and thymidine phosphorylase are expressed in esophageal, breast, cervical, ... Doxifluridine is a second generation nucleoside analog prodrug developed by Roche and used as a cytostatic agent in ... Doxifluridine (5´-deoxy-5-fluorouridine) is a fluoropyrimidine derivative of 5-FU, thus a second-generation nucleoside prodrug ...
The chemical compound 5-methyluridine (symbol m⁵U or m5U), also called ribothymidine (rT), is a pyrimidine nucleoside. It is ...
This is the first step in the production of the pyrimidine nucleoside triphosphates required for RNA and DNA synthesis. In ... In certain cancer cell lines, pyrimidine biosynthesis primarily occurs through the salvage pathway. Blocking pyrimidine salvage ... Binding specificity for nucleosides is determined by the His-117 and Tyr-112 residues, which hydrogen bond with the 4-amino ... Pyrimidine biosynthesis can occur through two pathways: de novo synthesis, which relies on L-glutamine as the pathway precursor ...
July 2015). "Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron ... Some antiviral drugs, such as acyclovir (ATC: J05AB01) and ganciclovir (ATC: J05AB06) as well as other nucleoside analogs make ... March 2006). "3-Carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapy". Anti ... September 2004). "Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors". ...
ENT3 is responsible for the trafficking of nucleoside, free purines and pyrimidines into the mitochondria and out of lysosomes ... The SLC29A3 gene is present in chromosome locus10q22.1, which encodes for the equilibrative nucleoside transporter 3 (ENT3), a ... Mutation leads to impaired ENT3 transportation activity, accumulation of nucleotides and nucleoside in lysosomes. As ... November 2012). "Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a ...
1999). "Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human ... Concentrative nucleoside transporters Nucleoside transporters Solute carrier family GRCh38: Ensembl release 89: ENSG00000137860 ... "Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2". J. ... Concentrative nucleoside transporter 2 (CNT2) is a protein that in humans is encoded by the SLC28A2 gene. ...
This enzyme is involved in the synthesis of pyrimidine nucleosides in the body, which are required for the synthesis of DNA and ...
1999). "Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human ... Concentrative nucleoside transporters Nucleoside transporters Solute carrier family GRCh38: Ensembl release 89: ENSG00000156222 ... 2004). "Transport of physiological nucleosides and anti-viral and anti-neoplastic nucleoside drugs by recombinant Escherichia ... broadly selective for purine and pyrimidine nucleosides (system cib)". Mol. Membr. Biol. 18 (1): 65-72. doi:10.1080/ ...
... pyrimidine nucleoside antibiotics". Ann N Y Acad Sci. 255 (1): 91-103. Bibcode:1975NYASA.255...91T. doi:10.1111/j.1749- ... Feun LG1, Blessing JA, Barrett RJ, Hanjani P. (December 1, 1993). "A phase II trial of tricyclic nucleoside phosphate in ... Triciribine is a cell-permeable unnatural nucleoside that inhibits the phosphorylation and signalling of all three family ... August 8, 1975). "Synthesis, chemical reactivity, and chemotherapeutic activity of certain selenonucleosides and nucleosides ...
... a pyrimidine-nucleoside phosphorylase (EC 2.4.2.2) is an enzyme that catalyzes the chemical reaction a pyrimidine nucleoside + ... the two substrates of this enzyme are pyrimidine nucleoside and phosphate, whereas its two products are pyrimidine base and ... "Purification and characterization of purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase from Bacillus ... The systematic name of this enzyme class is pyrimidine-nucleoside:phosphate alpha-D-ribosyltransferase. This enzyme is also ...
Crystal structure of a putative pyrimidine-nucleoside phosphorylase from Staphylococcus aureus ... Pyrimidine-nucleoside phosphorylase. A. 436. Staphylococcus aureus subsp. aureus COL. Mutation(s): 1 Gene Names: pdp, pyn, ... Crystal structure of a putative pyrimidine-nucleoside phosphorylase from Staphylococcus aureus. Shumilin, I.A., Zimmerman, M., ... Crystal structure of a putative pyrimidine-nucleoside phosphorylase from Staphylococcus aureus. *PDB DOI: https://doi.org/ ...
Selective Abolishment of Pyrimidine Nucleoside Kinase Activity of Herpes Simplex Virus Type 1 Thymidine Kinase by Mutation of ... Selective Abolishment of Pyrimidine Nucleoside Kinase Activity of Herpes Simplex Virus Type 1 Thymidine Kinase by Mutation of ...
Pyrimidine Nucleosides Analogues as Mycobacteria Growth Inhibitors. DOI: 10.37247/PAMICR3ED.3.22.7Download ...
Protein target information for Pyrimidine/purine nucleoside phosphorylase (Azotobacter vinelandii DJ). Find diseases associated ...
Crystal Structure of the E.coli pyrimidine nucleoside hydrolase yeiK ... Crystal Structure of the E.coli pyrimidine nucleoside hydrolase yeiK Coordinates. PDB Format Method. X-RAY DIFFRACTION 1.70 Å. ... Giabbai, B. et al., Crystal structure to 1.7 a of the Escherichia coli pyrimidine nucleoside hydrolase YeiK, a novel candidate ...
Influence of O(2)-C(2) cyclization on the sugar conformation of pyrimidine nucleosides. ...
involved_in pyrimidine nucleoside metabolic process NAS Non-traceable Author Statement. more info ... Pyrimidine-5-nucleotidase Campinas, a new mutation (p.R56G) in the NT5C3 gene associated with pyrimidine-5-nucleotidase type ... Pyrimidine-5-nucleotidase Campinas is a new mutation (p.R56G) in the NT5C3 gene associated with pyrimidine-5-nucleotidase ... Title: Pyrimidine-5-nucleotidase Campinas, a new mutation (p.R56G) in the NT5C3 gene associated with pyrimidine-5- ...
Pyrimidine nucleoside phosphorylase from Bacillus subtilis (BsPyNP, E.C. 2.4.2.3) and thymidine phosphorylase from Escherichia ... Pyrimidine nucleoside phosphorylase from Bacillus subtilis (BsPyNP, E.C. 2.4.2.3) and thymidine phosphorylase from Escherichia ... A comparison between immobilized pyrimidine nucleoside phosphorylase from Bacillus subtilis and thymidine phosphorylase from ... 2013). A comparison between immobilized pyrimidine nucleoside phosphorylase from Bacillus subtilis and thymidine phosphorylase ...
peptidyl pyrimidine nucleoside. polyoxin D. Locally systemic. 28. Carbamate. propamocarb. Locally systemic. ...
29 nucleosides, nucleotides, and analogs (18.24%, pyrimidine ribonucleotides); 13 organoheterocyclic compounds (8.18%, ...
Protein Pyrimidine nucleoside hydrolase YeiK [102633] (1 species). *. Species Escherichia coli [TaxId:562] [102634] (3 PDB ... Superfamily c.70.1: Nucleoside hydrolase [53590] (2 families) *. Family c.70.1.1: Nucleoside hydrolase [53591] (5 proteins). ... d3mknb_ c.70.1.1 (B:) Pyrimidine nucleoside hydrolase YeiK {Escherichia coli [TaxId: 562]} ... d3mknb_ c.70.1.1 (B:) Pyrimidine nucleoside hydrolase YeiK {Escherichia coli [TaxId: 562]} ...
Azacitidine is a pyrimidine nucleoside analog of cytidine that inhibits DNA/RNA methyltransferases. Azacitidine is incorporated ... Azacitidine is a nucleoside metabolic inhibitor with a molecular formula of C8H12N4O5 and a molecular weight of 244 g/mol. The ... ONUREG is a nucleoside metabolic inhibitor indicated for continued treatment of adult patients with acute myeloid leukemia who ...
3-Carbon-substituted pyrimidine nucleosides having a 2,3-dideoxy and 2,3-didehydro-2,3-dideoxy structure: synthesis and ... Phosphoralaninate pronucleotides of pyrimidine methylenecyclopropane analogues of nucleosides: synthesis and antiviral activity ... A new approach to the synthesis of 4-carbon-substituted nucleosides: development of a highly active anti-HIV agent 2, 3- ... Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting ...
Gemcitabine, a chemotherapeutic pyrimidine nucleoside prodrug, may cause SKM injury by a direct mechanism. These SKM side ... Improved diagnostics of purine and pyrimidine metabolism disorders using LC-MS/MS and its clinical application ...
1979) Metabolism of pyrimidine bases and nucleosides in Neisseria meningitidis Journal of Bacteriology 138:320-323. ... 2009) A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels Pharmaceutical Research 26:1504-1515. ... Despite the clear role of eATP as a plant damage-associated molecular pattern, the function of its nucleoside, eAdo, and of the ... RNRs catalyze the de novo conversion of the nucleoside diphosphates adenosine (A), guanosine (G), cytidine (C), and uridine (U ...
In vitro studies have shown ribavirin can reduce the phosphorylation of pyrimidine nucleoside analogues such as zidovudine. ... RETROVIR is the brand name for zidovudine (formerly called azidothymidine [AZT]), a pyrimidine nucleoside analogue active ... Nucleoside Analogues Affecting DNA Replication Some nucleoside analogues affecting DNA replication, such as ribavirin, ... RETROVIR is a nucleoside analogue reverse transcriptase inhibitor indicated for: •. Treatment of Human Immunodeficiency Virus ( ...
Nucleic Acids, Nucleotides, and Nucleosides [D13]. *Nucleosides [D13.570]. *Pyrimidine Nucleosides [D13.570.685] ... A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine ...
Targeting class I aminoacyl-tRNA synthetases with pyrimidine substituted aminoacyl-sulfamoyl nucleosides. ...
... was enabled with previous innovations in nucleoside modifications during in vitro transcription and lipid nanoparticle delivery ... A systematic study and comparison of 5-substituted pyrimidine and 7-substituted 7-deazapurine nucleoside triphosphates as ... Nucleoside modified (m1ψ-mRNA/LNPs). Mice: i.d. (3, 10, 30 μg). Mice: i.m. (10, 30, 90 μg). Ferrets: i.m./30 μg. [122]. ... Nucleoside modified/LNPs. Adults: i.m./H7N9 mRNA 10, 25, 50 μg; i.m./H10N8 mRNA 25, 50, 75, 100, 400 μg; i.d./25, 50 μg. [22]. ...
Design and synthesis of novel5-substituted acyclic pyrimidine nucleosides as potent and selectiveinhibitors of hepatitis B ... Thiadiazoles, pyrimidines, chalcones, thiourea and anticancer activity. In recent years pyrimidine derivatives have received ... For the preparation of 4, 6-disubstituted pyrimidine- 2-thiols (2a-i) a mixture of appropriate chalcones (1a-i, Scheme 1) (0.01 ... For preparation of 5-{[(4,6-disubstituted pyrimidine- 2-yl) thio] methyl}-N-phenyl-1,3,4-thiadiazol-2- amine (6a-c), a mixture ...
Development of High‐Performance Pyrimidine Nucleoside and Oligonucleotide Diarylethene Photoswitches,. Theresa Kolmar, Simon M ... Andres Jäschke, Heidelberg University, Germany, and colleagues have developed pyrimidine nucleosides with the structural ... This is the first systematic structure-activity study of pyrimidine nucleoside‐based diarylethenes photoswitches. ...
The alterations of pyrimidine nucleoside metabolism are hypothesized to cause imbalances of mitochondrial nucleotide pools that ...
Nucleosides and Nucleotides,Pyrimidines,De Novo Pyrimidine Synthesis,Pyrimidine operon regulatory protein PyrR. Nucleosides and ... De Novo Pyrimidine Synthesis,Uracil phosphoribosyltransferase (EC 2.4.2.9). Nucleosides and Nucleotides,Pyrimidines,pyrimidine ...
... but even this failed to form pyrimidine nucleosides.. *They must combine with phosphate to form a nucleotide. Yet phosphate ... They must combine with ribose to form a nucleoside. But this reaction just doesnt occur in water. And even in a dry ... In particular, the bases found were uracil, a pyrimidine (single-ringed base), and xanthine, a purine (double-ringed base). ... But even then, polymerization must have first occurred without a template, and pyrimidines wont polymerize even with a ...
... is a mitochondrial matrix protein encoded in nuclear DNA and phosphorylates the pyrimidine nucleosides: thymidine and ... Exon 5 encodes the α4 helix, which is required for enzyme dimerisation and nucleoside recognition in the deoxynucleoside kinase ... For these disorders, treatment with nucleotides/nucleosides has ameliorated phenotypic and biochemical abnormalities in ... mitochondrial enzyme that catalyses the conversion of deoxycytidine and thymidine nucleosides to their nucleoside ...
Uridine is a Pyrimidine nucleoside that has dramatic positive physiological effects to reduce abnormal nerve firing patterns in ... Uridine 5′-monophosphate 300 mg is a Pyrimidine nucleoside that has dramatic positive physiological effects to reduce abnormal ... URIDINE Pyrimidine Acetylcholine RNA DNA Enhanced Production, for ADD ADHD Aspergers Syndrome, CNS Vision Balance Motor Power ... URIDINE (Triacetyluridine) Uridine is a nucleoside that is formed when uracil is attached to a ribose ring. Uridine has a ...
In vitro studies have shown ribavirin can reduce the phosphorylation of pyrimidine nucleoside analogues such as stavudine. ... Stavudine is a nucleoside reverse transcriptase inhibitor that is FDA approved for the treatment of human immunodeficiency ... Stavudine, a nucleoside analogue of thymidine, is phosphorylated by cellular kinases to the active metabolite stavudine ... Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside ...
  • Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. (bvsalud.org)
  • When the diet contains nucleotides, the body digests them by nucleotidases to produce nucleosides and phosphates. (biologyonline.com)
  • Cytidine, just as the other nucleosides, can give rise to nucleotides. (biologyonline.com)
  • In enzymology, a pyrimidine-nucleoside phosphorylase (EC 2.4.2.2) is an enzyme that catalyzes the chemical reaction a pyrimidine nucleoside + phosphate ⇌ {\displaystyle \rightleftharpoons } a pyrimidine base + alpha-D-ribose 1-phosphate Thus, the two substrates of this enzyme are pyrimidine nucleoside and phosphate, whereas its two products are pyrimidine base and alpha-D-ribose 1-phosphate. (wikipedia.org)
  • Pyrimidine nucleoside phosphorylase from Bacillus subtilis (BsPyNP, E.C. 2.4.2.3) and thymidine phosphorylase from Escherichia coli (EcTP, E.C. 2.4.2.4) were used, as immobilized enzymes, in the synthesis of 5-halogenated pyrimidine 2′-deoxyribonucleosides (14-18) by transglycosylation in fully aqueous medium. (unimib.it)
  • The pyrimidine nucleoside phosphorylase Y03 is of bacterial origin and thermostable up to 60°C. Pyrimidine nucleoside phosphorylases catalyze the reversible phosphorolytic breakdown of the N-glycosidic bond of the pyrimidine nucleosides uridine, thymidine and 2'-deoxyuridine with the formation of the corresponding pyrimidine base and pentose-1-phosphate. (bionukleo.com)
  • Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues including RETROVIR. (drugs.com)
  • Clevudine is a synthetic pyrimidine nucleoside analog antiviral agent with activity against hepatitis B virus (HBV) and Epstein-Barr virus (EBV). (prosci-inc.com)
  • The systematic name of this enzyme class is pyrimidine-nucleoside:phosphate alpha-D-ribosyltransferase. (wikipedia.org)
  • Optimization of 5-fluoro-2′-deoxyuridine (14) synthesis (pH 7.5, 10 mM phosphate buffer, nucleoside/nucleobase 3:1 molar ratio) and subsequent scale-up afforded the target compound in 73% (EcTP) or 76% (BsPyNP) conversion (about 9 g/L). (unimib.it)
  • Thus, a nucleotide is a nucleoside with a phosphate group. (biologyonline.com)
  • Crystal structure to 1.7 a of the Escherichia coli pyrimidine nucleoside hydrolase YeiK, a novel candidate for cancer gene therapy. (expasy.org)
  • Here we analyze the distribution of genes encoding for putative NH proteins and characterize the yeiK gene product from Escherichia coli as a pyrimidine-specific NH. (rhea-db.org)
  • Enzymes with nucleoside hydrolase (NH) activity are crucial for salvaging nucleic acid components in purine auxotrophic protozoan parasites, but are also present in prokaryotes and higher eukaryotes. (rhea-db.org)
  • Nucleosides such as cytidine can be produced by de novo synthesis pathways in the liver. (biologyonline.com)
  • A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. (umassmed.edu)
  • The lack of a 3'-OH group in the incorporated nucleoside analogue prevents the formation of the 5' to 3' phosphodiester linkage essential for DNA chain elongation, and therefore, the viral DNA growth is terminated. (drugbank.com)
  • KP-1461 , a cytidine analogue belonging to the class of nucleoside reverse transcriptase inhibitors, has a potential use as a treatment for HIV/AIDS. (biologyonline.com)
  • In particular, the bases found were uracil , a pyrimidine (single-ringed base), and xanthine , a purine (double-ringed base). (creation.com)
  • URIDINE (Triacetyluridine) Uridine is a nucleoside that is formed when uracil is attached to a ribose ring. (nutrimedical.com)
  • This enzyme participates in pyrimidine metabolism. (wikipedia.org)
  • This enzyme is involved in the breakdown of molecules called pyrimidines, which are building blocks of DNA and its chemical cousin RNA. (medlineplus.gov)
  • The beta-ureidopropionase enzyme is involved in the last step of the process that breaks down pyrimidines. (medlineplus.gov)
  • 2020) Identification and Characterization of Enzymes Involved in the Biosynthesis of Pyrimidine Nucleoside Antibiotics. (uni-tuebingen.de)
  • The alterations of pyrimidine nucleoside metabolism are hypothesized to cause imbalances of mitochondrial nucleotide pools that, in turn, may cause somatic alterations of mtDNA. (nih.gov)
  • When phosphorylated by kinases, the nucleoside is converted into a nucleotide. (biologyonline.com)
  • The first structural and functional characterization of a nonparasitic, pyrimidine nucleoside-specific NH suggests a possible role for these enzymes in the metabolism of tRNA nucleosides. (rhea-db.org)
  • A nucleoside is a nucleobase with a five-carbon sugar (either ribose or deoxyribose). (biologyonline.com)
  • A pyrimidine nucleoside is one in which the nucleobase is a pyrimidine, such as cytosine in cytidine. (biologyonline.com)
  • Definition noun plural: cytidines cy·ti·dine, ˈsaɪtɪdiːn A pyrimidine nucleoside that has cytosine attached to the pentose sugar ribose Details Overview A nucleoside is a nucleobase with a five-carbon sugar (either ribose or deoxyribose). (biologyonline.com)
  • Cytidine is a nucleoside consisting of cytosine and ribose sugar linked by β-N 1 -glycosidic bond. (biologyonline.com)
  • URIDINE Pyrimidine Acetylcholine RNA DNA Enhanced Production, for ADD ADHD Asperger's Syndrome, CNS Vision Balance Motor Power and Memory and Recall Higher Functions. (nutrimedical.com)
  • Uridine is a Pyrimidine nucleoside that has dramatic positive physiological effects to reduce abnormal nerve firing patterns in seizure, ADHD and ADD, autism and toxic CNS neuropathy and organic brain syndrome. (nutrimedical.com)
  • This gene encodes a member of the 5'-nucleotidase family of enzymes that catalyze the dephosphorylation of nucleoside 5'-monophosphates. (nih.gov)
  • A New Homozygous Mutation (c.393-394del TA/c.393-394del TA) in the NT5C3 Gene Associated With Pyrimidine-5'-Nucleotidase Deficiency: A Case Report. (nih.gov)
  • The encoded protein is the type 1 isozyme of pyrimidine 5' nucleotidase and catalyzes the dephosphorylation of pyrimidine 5' monophosphates. (nih.gov)
  • ONUREG is a nucleoside metabolic inhibitor indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy ( 1 ). (nih.gov)
  • These are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. (drugbank.com)
  • The unprecedently speedy development of mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was enabled with previous innovations in nucleoside modifications during in vitro transcription and lipid nanoparticle delivery materials of mRNA. (mdpi.com)
  • A number of substituted-a,β -unsaturated carbonyl compounds (1a-i) were prepared by Claisen-Schmidt condensation of substituted acetophenone with selected araldehydes, which on cycloaddition with thiourea furnished 4,6-disubstituted pyrimidine-2-thiols (2a-i). (ijpsonline.com)
  • Condensation of compounds (4a-c) with phenyl isothiocyanate gave 2-{[(4,6-disubstituted pyrimidine-2-yl) thio] acetyl}-N-phenylhydrazinecarbothioamides (5a-c) which on treatment with concentrated sulphuric acid afforded titled compounds 5-{(4,6-disubstituted pyrimidine-2-yl) thio] methyl}-N-phenyl-1,3,4-thiadiazole-2-amines (6a-c). (ijpsonline.com)
  • This compound belongs to the class of organic compounds known as pyrimidine nucleosides. (drugbank.com)
  • This is the first systematic structure-activity study of pyrimidine nucleoside‐based diarylethenes photoswitches. (chemistryviews.org)
  • Andres Jäschke, Heidelberg University, Germany, and colleagues have developed pyrimidine nucleosides with the structural features of diarylethenes. (chemistryviews.org)
  • Considering the above facts, the goal of the present study was to combine disubstituted pyrimidines with 1,3,4-thiadiazole residues in order to develop hybrid molecules with potential of enhanced activity and to test their antioxidant and antitumor activities. (ijpsonline.com)
  • Stavudine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). (drugbank.com)
  • Reaction of (2a-i) with ethyl chloroacetate followed by condensation with hydrazine hydrate yielded 2-[(4,6-disubstituted pyrimidine-2-yl) thio] acetohydrazides (4a-c). (ijpsonline.com)
  • Stavudine is a nucleoside reverse transcriptase inhibitor that is FDA approved for the treatment of human immunodeficiency virus (HIV)-1 infection. (wikidoc.org)
  • Specifically, YibK requires a pyrimidine nucleoside at position 34, it has a clear preference for an adenosine at position 35, and it fails to methylate without prior addition of the N(6)-(isopentenyl)- 2-methylthioadenosine modification at position 37. (cathdb.info)
  • A) in NT5C3A associated with hereditary pyrimidine 5'-nucleotidase deficiency: two cases report and literature review]. (nih.gov)

No images available that match "pyrimidine nucleosides"